Background Plant proteins are well-known precursors of bioactive peptides. In translating the peptides into functional foods, the protein sources need to be sustainable and readily available. Ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) is the major enzyme in photosynthesis and photorespiration in plants and some other organisms, and is known to be the most abundant protein on earth. Therefore, RuBisCO is an attractive and sustainable source of bioactive peptides. Scope and approach This review discusses the structure, function, composition and technology for plant RuBisCO extraction, as well as the fractionation and known bioactivities of its enzymatic hydrolysate and peptides. Feasibility of industrial scale up and practical application of the RuBisCO peptides in food were also considered. Key findings and conclusions Several processes are available for extraction of the RuBisCO subunits and some are simple, fast and adaptable for industrial scale production. Work is however needed on recovery of high protein yields with high purity. Most studies reported that peptides, mostly from the large subunit, from enzymatic hydrolysis of spinach or alfalfa RuBisCO possess antihypertensive, opioid-like, secretagogue and food intake stimulating, antioxidant and antimicrobial activities. These properties demonstrate that RuBisCO can be utilized as a sustainable source of peptides with multiple bioactivities for formulation of functional foods
The sugar β-L-rhamnose is often a conserved component of bacterial polysaccharide capsules, an extracellular structure featured in many drug-resistant, pathogenic bacteria. The β-L-rhamnose biosynthetic enzymes (RmlA-D) have therefore become key targets in antibiotic development. However, inhibitor discovery for these enzymes, particularly α-D-glucose-1-phosphate thymidylyltransferase, has been hindered by a lack robust activity assays. To address this challenge, we report a continuous, coupled-enzyme assay for screening α-D-glucose-1-phosphate thymidylyltransferase inhibitors, using Streptococcus pneumoniae Cps2L as a model enzyme. This platform was used to characterize ligand binding to Cps2L, identifying uridine diphosphate α-D- glucose and pyrophosphate as substrates of the reverse pyrophosphorylase reaction, and to explore inhibition by thymidine diphosphate-β-L-rhamnose (TDP-Rha). A rapidly reversible binding mechanism at the allosteric site was identified for TDP-Rha (IC50 = 45.1 ± 2.3 μM) using progress curve shape analysis and an engineered E253D Cps2L variant. Offering high-throughput capabilities and detailed kinetic resolution, the developed assay is well-suited for inhibitor discovery and mechanistic characterization.